Pharmacokinetics of Heparin and of Dermatan Sulfate: Clinical Implications
- 1 January 1992
- book chapter
- Published by Springer Nature
- Vol. 313, 237-247
- https://doi.org/10.1007/978-1-4899-2444-5_24
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Heparin half‐life and sensitivity in normal subjects and in patients affected by deep vein thrombosisEuropean Journal of Clinical Investigation, 1986
- Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.Journal of Clinical Investigation, 1985
- Circadian changes in anticoagulant effect of heparin infused at a constant rate.BMJ, 1985
- Heparin Requirements in Pulmonary Embolism and Venous Thrombosis: A Prospective StudyThe Journal of Clinical Pharmacology, 1982
- Heparin Pharmacokinetics: Increased Requirements in Pulmonary EmbolismBritish Journal of Haematology, 1978
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- The heterogeneity of the anticoagulant response to heparinJournal of Clinical Pathology, 1972
- The Fate of Heparin in Rabbits after Intravenous InjectionActa Pharmacologica et Toxicologica, 1947